Catastrophic antiphospholipid syndrome in pregnancy, a diagnosis that should not be missed

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 29, Issue 24, 2016, Pages 3950-3955

  Hoayek, Jennifer G ^a   Moussa, Hind N ^a   Rehman, Hina A ^a   Nasab, Susan Hosseini ^a   Blackwell, Sean C ^a   Sibai, Baha M ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

AFLP; antiphospholipid antibody; antiphospholipid syndrome; HELLP; imitators of preeclampsia; organ thrombosis

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY;

ABDOMINAL PAIN; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; DELAYED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; DYSPNEA; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HELLP SYNDROME; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; LIVER FATTY DEGENERATION; MALAISE; PREGNANCY DISORDER; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; SEIZURE; SENSITIVITY AND SPECIFICITY; FEMALE; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIPLE ORGAN FAILURE; PREGNANCY; PREGNANCY COMPLICATIONS;

ANTIPHOSPHOLIPID SYNDROME; COMBINED MODALITY THERAPY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MULTIPLE ORGAN FAILURE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 84977267246     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2016.1160047     Document Type: Review

References (28)

1. Gómez-Puerta JA, Espinosa G, Cervera R. Catastrophic antiphospholipid syndrome:diagnosis and management in pregnancy. Clin Lab Med 2013;33:391–400.
2. Cervera R, Bucciarelli S, Plasín MA, et al Catastrophic antiphospholipid syndrome (CAPS):descriptive analysis of a series of 280 patients from the “CAPS Registry”. J Autoimmun 2009;32:240–5.
3. Asherson RA. The catastrophic antiphospholipid (Asherson’s) syndrome in 2004–a review. Autoimmun Rev 2005;4:48–54.
4. Cervera R, Rodríguez-Pintó I, Colafrancesco S, et al 14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. Autoimmun Rev 2014;13:699–707.
5. Stojanovich L, Marisavljevic D, Rovensky J, et al Clinical and laboratory features of the catastrophic antiphospholipid syndrome. Clin Rev Allergy Immunol 2009;36:74–9.
6. Mar N, Kosowicz R, Hook K., Recurrent thrombosis prevention with intravenous immunoglobulin and hydroxychloroquine during pregnancy in a patient with history of catastrophic antiphospholipid syndrome and pregnancy loss. J Thromb Thrombolysis 2014;38:196–200.
7. Sibai BM., Imitators of severe pre-eclampsia. Semin Perinatol 2009;33:196–205.
8. Bucciarelli S, Cervera R, Espinosa G, et al Mortality in the catastrophic antiphospholipid syndrome:causes of death and prognostic factors. Autoimmun Rev 2006;6:72–5.
9. Gómez-Puerta JA, Sanin-Blair J, Galarza-Maldonado C., Pregnancy and catastrophic antiphospholipid syndrome. Clin Rev Allergy Immunol 2009;36:85–90.
10. Asherson RA. Multiorgan failure and antiphospholipid antibodies:the catastrophic antiphospholipid (Asherson’s) syndrome. Immunobiology 2005;210:727–33.
11. Espinosa G, Berman H, Cervera R., Management of refractory cases of catastrophic antiphospholipid syndrome. Autoimmun Rev 2011;10:664–8.
12. Gómez-Puerta Ja, Cervera R, Espinosa G, et al Pregnancy and puerperium are high susceptibility periods for the development of catastrophic antiphospholipid syndrome. Autoimmun Rev 2006;6:85–8.
13. Gomez-Puerta JA, Cervera R, Espinosa G, et al Catastrophic antiphospholipid syndrome during pregnancy and puerperium:maternal and fetal characteristics of 15 cases. Ann Rheum Dis 2007;66:740–6.
14. Nayer A, Ortega LM., Catastrophic antiphospholipid syndrome:a clinical review. J Nephropathol 2014;3:9–17.
15. Cervera R, Rodriguez-Pinto I, Espinosa G, Catastrophic TF., Catastrophic antiphospholipid syndrome:task force report summary. Lupus 2014;23:1283–5.
16. Aguiar CL, Erkan D., Catastrophic antiphospholipid syndrome:how to diagnose a rare but highly fatal disease. Ther Adv Musculoskelet Dis 2013;5:305–14.
17. Hanouna G, Morel N, Le Thi Huong D, et al Catastrophic antiphospholipid syndrome and pregnancy:an experience of 13 cases. Rheumatology 2013;52:1635–41.
18. Sibai BM., Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004;103:981–91.
19. Moussa HN, Sibai BM., Management of hypertensive disorders in pregnancy. Womens Health 2015;10:385–404.
20. Haddad B, Sibai BM., Expectant management in pregnancies with severe pre-eclampsia. Semin Perinatol 2009;33:143–51.
21. Knox TA, Olans LB., Liver disease in pregnancy. N Engl J Med 1996;335:569–576.
22. Cervera RR., Update on the catastrophic antiphospholipid syndrome and the “CAPS Registry”. Semin Thromb Haemost 2012;38:333–8.
23. Lockshin MD., Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy. Clin Lab Med 2013;33:367–76.
24. Bayraktar UD, Erkan D, Bucciarelli S, et al The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J Rheumatol 2007;34:346–52.
25. Pauzner R, Dulitzky M, Carp H, et al Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome. J Thromb Haemost 2003;1:1758–63.
26. Berkelhammer C, Patel N, Chen J, et al Hepatic infarction during pregnancy in catastrophic antiphospholipid syndrome. J Gastroenterol Hepatol 2007;22:1695–6.
27. Scheiman Elazary A, Cohen MJ, Aamar S, et al Pulmonary hemorrhage in antiphospholipid antibody syndrome. J Rheumatol 2012;39:1628–31.
28. Cervera R, Piette J-C, Font J, et al Antiphospholipid syndrome:clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002;46:1019–27.